CheckMate-032 Study: promising efficacy with nivolumab-based immunotherapy in pretreated esophagogastric cancer.

CheckMate-032 Study: promising efficacy with nivolumab-based immunotherapy in pretreated esophagogastric cancer. J Thorac Dis. 2019 Mar;11(Suppl 3):S394-S395 Authors: Sun S, Kim JJ, Ko YH PMID: 30997229 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research